Seaport Therapeutics management team will present at Stifel 2025 Healthcare Conference on November 11 at 10:00AM EST.

A Relative Strength Rating upgrade for Stifel Financial shows improving technical performance. Will it continue?

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target discovery powered by AI/ML, today announced that Compugen ...

A. O. Smith Corporation (NYSE: AOS) is included among the 13 Best Consistent Dividend Stocks to Buy Now.

Fintel reports that on November 3, 2025, Stifel reiterated coverage of Disc Medicine (NasdaqGM:IRON) with a Buy recommendation. Analyst Price Forecast Suggests 28.84% Upside As of October 30, 2025, ...

Pet Valu sees weaker demand for non-essential pet products through 2026 but expects steady food sales and long-term growth ...

TORONTO, Nov. 4, 2025 /CNW/ - GreenLight Metals Inc. (TSXV: GRL) ("GreenLight" or the "Company") announced today that it has entered into an ...

The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...

According to new data released by Intuit Credit Karma in September of this year, 66% of Americans surveyed who had previously ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

D-Wave Quantum (NYSE:QBTS) has been on a rally that exceeded bullish expectations several times over. This is largely thanks to the company’s management pulling off a PR offensive and then turning it ...

With the 2025-26 season on the horizon, Copper Mountain is gearing up for a season full of fresh turns, events and ...